Core Viewpoint - The company, BioPharm (600201.SH), has received approval from the Ministry of Agriculture and Rural Affairs for a new veterinary drug, a genetically engineered subunit vaccine for Clostridium perfringens type A, developed in collaboration with other companies [1] Group 1 - The vaccine has been approved as a new veterinary drug according to national regulations [1] - The approval includes the issuance of a New Veterinary Drug Registration Certificate [1] - The vaccine is developed by the company's wholly-owned subsidiary, Jinyu Baoling Biological Pharmaceutical Co., Ltd. [1]